Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 12 November 2018 |
| Author/s |
author: Holger Lode Peter F Ambros Maja Beck Popovic Penelope Brock Ulrike Pötschger Maria Rita Castellani Toby Trahair Alberto Garaventa |
| Publication date | November 12, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |